Skip to main content
Premium Trial:

Request an Annual Quote

Emory University Purchases Corning Epic System for Drug Studies

NEW YORK (GenomeWeb News) — Emory University has added one of Corning’s label-free screening systems for use in its drug discovery research programs, the company said yesterday.
The university bought the Epic System for use in its Emory Chemical Biology Discovery Center, which is part of the National Institutes of Health-funded Molecular Libraries Screening Centers Network. The MLSCN includes ten screening centers that work to develop new chemical probes for drug research.
The Epic System is able to conduct biochemical and cell-based assays without radioactive or fluorescent dyes that could interfere with chemical reactions, said Corning.
Ron Verkleeren, who is business director for the Epic System, said in a statement that the instrument’s ability to monitor real-time responses of small molecular compounds in living cells will help streamline the university’s search for new drugs.

Financial terms of the agreement were not released.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.